TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TALPHERA, INC. (TLPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.67 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 214.90K shares, a 70.47% decline year-over-year.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.45M shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 191.98K shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 919.78K shares, a 12.70% decline from fiscal 2024.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.05M shares, a 264.66% increase from fiscal 2023.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 288.93K shares.
- TALPHERA, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 2.67M shares, a 46.85% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 214.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 1.67M shares 10-Q · filed 2026-08-12 | 1.86M shares derived: sum of 3 quarters · filed 2026-08-12 | 1.86M shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 1.45M shares 10-Q · filed 2026-05-13 | 1.64M shares derived: sum of 2 quarters · filed 2026-05-13 | 1.64M shares derived: sum of 3 quarters · filed 2026-05-13 | 2.37M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 191.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 191.98K shares derived: sum of 2 quarters · filed 2026-03-23 | 919.78K shares derived: sum of 3 quarters · filed 2026-03-23 | 919.78K shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 727.80K shares derived: sum of 2 quarters · filed 2025-11-12 | 727.80K shares 10-Q · filed 2025-11-12 | 727.80K shares derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 727.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 727.80K shares 10-Q · filed 2025-08-14 | 727.80K shares derived: sum of 3 quarters · filed 2026-03-23 | 727.80K shares derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-23 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-23 | 263.26K shares derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-23 | 263.26K shares derived: sum of 3 quarters · filed 2026-03-23 | 1.05M shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 263.26K shares derived: sum of 2 quarters · filed 2024-11-13 | 1.05M shares 10-Q · filed 2024-11-13 | 1.08M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | 263.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 1.05M shares 10-Q · filed 2024-08-14 | 1.08M shares derived: sum of 3 quarters · filed 2025-03-31 | 1.08M shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | 790.35K shares 10-Q · filed 2024-05-14 | 814.76K shares derived: sum of 2 quarters · filed 2025-03-31 | 814.76K shares derived: sum of 3 quarters · filed 2025-03-31 | 814.76K shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | 24.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 24.41K shares derived: sum of 2 quarters · filed 2025-03-31 | 24.41K shares derived: sum of 3 quarters · filed 2025-03-31 | 288.93K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-14 | 264.52K shares 10-Q · filed 2023-11-14 | 264.51K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 264.52K shares 10-Q · filed 2023-08-10 | 264.51K shares derived: sum of 3 quarters · filed 2023-08-10 | -1.74M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 264.52K shares 10-Q · filed 2023-05-10 | 264.51K shares derived: sum of 2 quarters · filed 2023-08-01 | -1.74M shares derived: sum of 3 quarters · filed 2023-08-01 | -1.74M shares derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-12-31 | -10.00 shares derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -2.01M shares derived: sum of 2 quarters · filed 2023-08-01 | -2.01M shares derived: sum of 3 quarters · filed 2023-08-01 | 117.02K shares 8-K · filed 2023-08-01 |
| 2022-09-30 | -2.01M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -2.01M shares derived: sum of 2 quarters · filed 2022-11-14 | 117.03K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 2.12M shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 2.12M shares 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | 2.67M shares 10-K · filed 2022-03-10 | |||
| 2020-12-31 | 1.82M shares 10-K · filed 2021-03-15 | |||
| 2019-12-31 | 2.06M shares 10-K · filed 2020-03-16 | |||
| 2018-12-31 | 3.55M shares 10-K · filed 2019-03-07 | |||
| 2017-12-31 | 3.01M shares 10-K · filed 2018-03-09 | |||
| 2016-12-31 | 1.89M shares 10-K · filed 2017-03-03 | |||
| 2015-12-31 | 560.50K shares 10-K · filed 2016-03-07 | |||
| 2014-12-31 | 2.51M shares 10-K · filed 2015-03-13 | |||
| 2013-12-31 | 1.96M shares 10-K · filed 2015-03-13 | |||
| 2012-12-31 | 1.21M shares 10-K · filed 2015-03-13 | |||
| 2011-12-31 | 514.96K shares 10-K · filed 2014-03-17 | |||
| 2010-12-31 | 1.44M shares 10-K · filed 2013-03-12 | |||
| 2009-12-31 | 231.88K shares 10-K · filed 2013-03-12 | |||
| 2008-12-31 | 196.88K shares 10-K · filed 2013-03-12 | |||
| 2007-12-31 | 290.63K shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |